MiNK Therapeutics (INKT) Interest Coverage Ratio (2020 - 2026)
MiNK Therapeutics (INKT) posted Interest Coverage Ratio of 720.45 for Q1 2026, up 2993.5% sequentially from 23.29 in Q4 2025, and up 673.62% YoY from 93.13 in Q1 2025.
MiNK Therapeutics (INKT) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
MiNK Therapeutics has reported Interest Coverage Ratio for 7 years, with the latest figure at 720.45 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 673.62% year-over-year to 720.45 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 175.59 (down 78.73% YoY) and the FY2025 annual result came in at 0.4, up 95.06% from the prior year.
- Interest Coverage Ratio improved to 720.45 in Q1 2026 per INKT's latest filing, from 23.29 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 720.45 in Q1 2026 and troughed at 953.49 in Q4 2022.
- A 5-year average of 19.3 and a median of 1.42 in 2023 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio tumbled 11966.45% in 2022, then jumped 26581.69% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 953.49 in 2022, then surged by 111.67% to 111.25 in 2023, then slumped by 129.54% to 32.86 in 2024, then soared by 170.87% to 23.29 in 2025, then jumped by 2993.5% to 720.45 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 720.45, 23.29, and 0.51 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 1.42 |
| 10 | MiNK Therapeutics | 60.53 Mn | 60.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.74 |
| Mar 31, 2026 | 720.45 |
| Dec 31, 2025 | 23.29 |
| Sep 30, 2025 | -0.51 |
| Jun 30, 2025 | -2.93 |
| Mar 31, 2025 | 93.13 |
| Dec 31, 2024 | -32.86 |
| Sep 30, 2024 | -1.25 |
| Jun 30, 2024 | -1.46 |
| Mar 31, 2024 | 383.00 |
| Dec 31, 2023 | 111.25 |
| Sep 30, 2023 | -2.27 |
| Jun 30, 2023 | -1.42 |
| Mar 31, 2023 | -1.45 |
| Dec 31, 2022 | -953.49 |
| Sep 30, 2022 | -1.71 |
| Jun 30, 2022 | -2.36 |
| Mar 31, 2022 | -1.28 |
| Dec 31, 2021 | -7.90 |
| Sep 30, 2021 | -1.66 |